Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Respiratory musculature refers to the ensemble of skeletal muscles (including the diaphragm, intercostal muscles, abdominal muscles, and accessory groups like the sternocleidomastoid and scalene muscles) responsible for ventilating the lungs by expanding and contracting the thoracic cavity. The diaphragm is the primary inspiratory muscle, with the intercostal and accessory muscles recruited during increased ventilatory demand or respiratory distress[1][2][3][4]. These muscles are subject to neuromuscular diseases, fatigue, and secondary involvement in pulmonary disorders, but they do not represent a canonical molecular therapeutic "target" like a receptor, ion channel, or enzyme[3][4][5]. Pharmacological intervention typically affects the innervating nerves or general muscle contractility, not the musculature itself at the molecular level.
Indirect—increase force generation or contractility (e.g., stimulants, some methylxanthines) Indirect—block signal transmission causing paralysis (e.g., neuromuscular blocking agents)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Respiratory muscle.